サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1632600

エラストマー製輸液ポンプの世界市場：市場規模・シェア・動向分析 (製品別・用途別・最終用途別・地域別・セグメント別、2025年～2030年)

Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
エラストマー製輸液ポンプの世界市場：市場規模・シェア・動向分析 (製品別・用途別・最終用途別・地域別・セグメント別、2025年～2030年)
出版日: 2024年12月24日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エラストマー製輸液ポンプの市場動向：

エラストマー製輸液ポンプの世界市場規模は2024年に6億7,980万米ドルと推計され、2025年から2030年にかけてCAGR 7.2%で成長すると予測されています。

がん、糖尿病、心血管障害などの慢性疾患の罹患率が上昇していることが、市場成長の大きな促進要因となっています。世界保健機関 (WHO) の統計によると、慢性疾患は世界の死亡原因のトップであり、世界全体の死亡原因の71%を占めています。このため、これらの疾患の効果的な治療と管理を確実にするために、エラストマーポンプのような連続ドラッグデリバリーシステムに対する需要が高まっています。

在宅医療ソリューションに対する需要の高まりは、エラストマー製輸液ポンプ業界を牽引する重要な要因です。患者は自宅で薬剤を投与できる治療法を好み、エラストマー製ポンプの携帯性と使いやすさはこのニーズに応えています。この動向は、高齢化によって慢性疾患の長期治療に対するニーズが高まっていることでさらに強まっています。2024年10月に発表された研究によると、骨髄炎は米国で年間約50,000人が罹患しており、小児、高齢者、男性の罹患率が高いです。脊椎骨と長骨が最もよく罹患する部位です。また、骨髄炎は女性よりも男性の方が罹患しやすいことが、現在の調査やこの病気に関する他の発表データから明らかになっています。

メーカーは、市場成長を促進するために、エラストマー製輸液ポンプ技術の強化に注力しています。これらの進歩には、より高い精度、より長い注入時間、改良された機能を備えたポンプの開発、利用しやすいデザインなどが含まれます。これらの技術革新は、患者や医療提供者の多様なニーズに対応し、エラストマー製輸液ポンプの効率を高め、信頼性と安全性を高めることを目的としています。2024年9月、Journal of Biosciences and Medicines誌に掲載された研究では、カテーテルを通して薬剤を供給するエラストマーポンプの理論モデルが発表されました。この研究では、臨床の流量が正確に再現され、球体の半径に関連する毒性バンプが特定されました。研究者らは、ポンプの特性を最適化することで、毒性の影響を最小限に抑えながら輸液時間を制御できると結論づけた。

オピオイド依存を減少させ、代替疼痛管理ソリューションへの患者のアクセスを改善しようとする動きが強まっていることは、医療政策の変更の大きな推進力となっています。2024年11月、Avanos Medical, Inc.は、メディケア・メディケイドサービスセンターが2025年のメディケア病院外来患者前向き支払いシステムおよび外来手術センター支払いシステム規則を最終決定し、2025年1月1日に発効することを報告しました。この更新では、NOPAIN法が導入され、メディケアは、病院外来および手術センター環境における疼痛管理ソリューションへの患者のアクセスを改善するために、対象となる非オピオイド医薬品および機器に対して明確な支払いを行うことが求められています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 エラストマー製輸液ポンプ市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • エラストマー製輸液ポンプ市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 エラストマー製輸液ポンプ市場：製品別の推定・動向分析

  • 世界のエラストマー製輸液ポンプ市場：製品別のダッシュボード
  • 世界のエラストマー製輸液ポンプ市場：製品別の変動分析
  • 世界のエラストマー製輸液ポンプ市場：製品別 (収益ベース)
  • 定速式エラストマー製輸液ポンプ
  • 変速式エラストマー製輸液ポンプ

第5章 エラストマー製輸液ポンプ市場：用途別の推定・動向分析

  • 世界のエラストマー製輸液ポンプ市場：用途別のダッシュボード
  • 世界のエラストマー製輸液ポンプ市場：用途別の変動分析
  • 世界のエラストマー製輸液ポンプ市場：用途別 (収益ベース)
  • 疼痛管理
  • 化学療法
  • 抗生物質/抗ウイルス療法
  • その他

第6章 エラストマー製輸液ポンプ市場：最終用途別の推定・動向分析

  • 世界のエラストマー製輸液ポンプ市場：最終用途別のダッシュボード
  • 世界のエラストマー製輸液ポンプ市場：最終用途別の変動分析
  • 世界のエラストマー製輸液ポンプ市場：最終用途別 (収益ベース)
  • 病院
  • 外来手術センター
  • その他

第7章 エラストマー製輸液ポンプ市場：地域別の推定・動向分析 (国別・製品別・用途別・最終用途別)

  • 地域別のダッシュボード
  • 市場規模の予測と動向分析 (2018年・2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 最新動向と影響分析：主要メーカー別
  • 企業/競合の分類
  • ベンダー情勢
    • 主な流通業者・チャネルパートナーの一覧
    • 主要顧客
    • 主要企業の市場シェア分析 (2024年)
  • 企業プロファイル
    • Baxter
    • Fresenius Kabi AG
    • B. Braun SE
    • Ambu A/S
    • Leventon, SAU
    • NIPRO
    • Terumo Corporation
    • AVNS
    • Vygon Group
    • Smiths Group plc
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global elastomeric infusion pumps market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 30 France elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 31 France elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 52 China elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 53 China elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 58 India elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 59 India elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Elastomeric infusion pumps market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Elastomeric Infusion Pumps Market: Product Outlook Key Takeaways
  • Fig. 15 Global Elastomeric Infusion Pumps Market: Product Movement Analysis
  • Fig. 16 Global Continuous Rate Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Variable Rate Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Elastomeric Infusion Pumps Market: Application Outlook Key Takeaways
  • Fig. 19 Global Elastomeric Infusion Pumps Market: Application Movement Analysis
  • Fig. 20 Global Pain Management Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Chemotherapy Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Antibiotic/Antiviral Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Elastomeric Infusion Pumps Market: End Use Outlook Key Takeaways
  • Fig. 25 Global Elastomeric Infusion Pumps Market: End Use Movement Analysis
  • Fig. 26 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Global Elastomeric Infusion Pumps Market: Region Movement Analysis
  • Fig. 32 North America Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 33 US Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia pacific Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 60 Strategy framework
目次
Product Code: GVR-4-68040-340-4

Elastomeric Infusion Pumps Market Trends:

The global elastomeric infusion pumps market size was estimated at USD 679.8 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030. The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a significant driver for market growth. According to statistics from the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for 71% of all deaths globally. This led to a higher demand for continuous drug delivery systems such as elastomeric pumps to ensure effective treatment and management of these conditions.

The growing demand for home healthcare solutions is a crucial factor driving the elastomeric infusion pumps industry. Patients prefer therapies that enable them to administer medications at home, and the portability and user-friendliness of elastomeric pumps cater to this need. This trend is amplified by the aging population's increasing requirement for long-term treatment of chronic conditions. According to a study published in October 2024, Osteomyelitis affects around 50,000 people annually in the U.S., with higher incidence in children, older adults, and males. Vertebrae and long bones are the most commonly involved sites. It also shows that males are more susceptible to Osteomyelitis than females, as evidenced by the current research and other published data on the disease.

Manufacturers are focusing on enhancing elastomeric infusion pump technologies to drive market growth. These advancements involve greater accuracy, longer infusion durations, developing pumps with improved features, and accessible designs. These innovations aim to cater to the diverse needs of patients and healthcare providers, enhancing the efficiency of elastomeric infusion pumps and making them dependable and secure. In September 2024, research published in the Journal of Biosciences and Medicines presented a theoretical model for elastomeric pumps, which deliver medications through a catheter. The study accurately reproduced clinical flow rates and identified a toxicity bump related to the sphere's radius. The researchers concluded that by optimizing pump properties, infusion times can be controlled while minimizing toxicity effects.

The increasing push to reduce opioid dependence and improve patient access to alternative pain management solutions has been a major driver in healthcare policy changes. In November 2024, Avanos Medical, Inc. reported that the Centers for Medicare and Medicaid Services has finalized its Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System regulations for 2025, set to take effect on January 1, 2025. This update introduces the NOPAIN Act, which requires Medicare to provide distinct payments for eligible non-opioid medications and devices to improve patient access to pain management solutions in hospital outpatient and surgical center environments.

Global Elastomeric Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global elastomeric infusion pumps market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Continuous Rate Elastomeric Infusion Pumps
  • Variable Rate Elastomeric Infusion Pumps
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Pain Management
  • Chemotherapy
  • Antibiotic/Antiviral Therapy
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Elastomeric Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Rising number of orthopedic surgeries
      • 3.2.1.3. Technological advancements in elastomeric infusion pumps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of elastomeric infusion pumps
      • 3.2.2.2. Regulatory standards
  • 3.3. Elastomeric Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Elastomeric Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. Global Elastomeric Infusion Pumps Market: Product Dashboard
  • 4.2. Global Elastomeric Infusion Pumps Market: Product Movement Analysis
  • 4.3. Global Elastomeric Infusion Pumps Market by Product, Revenue
  • 4.4. Continuous Rate Elastomeric Infusion Pumps
    • 4.4.1. Continuous Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Variable Rate Elastomeric Infusion Pumps
    • 4.5.1. Variable Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Elastomeric Infusion Pumps Market: Application Estimates & Trend Analysis

  • 5.1. Global Elastomeric Infusion Pumps Market: Application Dashboard
  • 5.2. Global Elastomeric Infusion Pumps Market: Application Movement Analysis
  • 5.3. Global Elastomeric Infusion Pumps Market by Application, Revenue
  • 5.4. Pain Management
    • 5.4.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Chemotherapy
    • 5.5.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Antibiotic/Antiviral Therapy
    • 5.6.1. Antibiotic/antiviral therapy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Elastomeric Infusion Pumps Market: End Use Estimates & Trend Analysis

  • 6.1. Global Elastomeric Infusion Pumps Market: End Use Dashboard
  • 6.2. Global Elastomeric Infusion Pumps Market: End Use Movement Analysis
  • 6.3. Global Elastomeric Infusion Pumps Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Elastomeric Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Baxter
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Fresenius Kabi AG
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. B. Braun SE
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Ambu A/S
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Leventon, S.A.U.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. NIPRO
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Terumo Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. AVNS
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Vygon Group
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Smiths Group plc
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives